Loading clinical trials...
Loading clinical trials...
The purpose of this study is to explore the effects of prolactin on adrenal steroid profiles in patients with hyperprolactinemia due to prolactinomas before and after initialisation of treatment.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
NCT07124221 · Hyperprolactinemia
NCT07008417 · Hyperprolactinemia
NCT05528393 · Gestational Diabetes Mellitus in Pregnancy, Hyperprolactinemia Pregnancy
NCT01338298 · Hyperprolactinemia
NCT03709849 · Anovulatory Infertility, Abnormal Uterine Bleeding-Ovulatory Disorders, and more
Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, Bern University Hospital
Bern
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions